Litigation

• Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
• Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
• Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
• Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine 
• Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required) 
• OxyElite Pro Class Action Filed Over False Advertising 
• First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014 
• J&J Takes Innovative, If Pricey, Route to Ending Hip Suits (subscription required) 

Regulatory

• Avandia REMS Program Modified by FDA to Loosen Restrictions 
• DNA Tests on Notice as FDA Warns Wife of Google’s Brin (subscription required) 
• FDA Scrutiny Looms for Unapproved Research Tests (subscription required)
• FDA Loosens Restrictions on GSK’s Avandia (subscription required) 
• FDA Calls Out Amgen Over Misleading Anemia Drug Claims (subscription required) 
• Rips “Troubling” Drug Promo in Repeat Warning Letter (subscription required) 

Recalls

• Abbott Issues Voluntary Recall of Certain FreeStyle® and FreeStyle Lite® Glucose Test Strips 
• Viscocel Recall Issued for Eye Solution Due to Lack of FDA Approval

For a look at last week’s important life science headlines, click here.